课题基金 / 基金详情

Adaptive response of bone to mechanical strain in a mouse model of myeloma bone disease

Adaptive response of bone to mechanical strain in a mouse model of myeloma bone disease
骨髓瘤骨病小鼠模型中骨对机械应变的适应性反应
批准号:
319916251
负责人:
Professorin Dr. Franziska Jundt
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2020-12-31

项目摘要

项目成果

Professorin Dr. Franziska Jundt的其他基金

相似基金

相关文献

中文摘要
翻译
骨骼适应不断变化的负荷(所谓的建模),并具有自我修复和更新(重塑)的能力。这些合成代谢过程使骨骼能够在很长一段时间内成功地执行其机械功能。骨骼对机械负荷的局部适应性反应在运动员训练中表现得最为显著。运动形式的机械负荷在癌症患者中进一步显示出有希望的结果,以保持骨结构强度并防止骨丢失。我们在多发性骨髓瘤(MM)骨疾病的MOPC315.BM小鼠模型中获得了初步数据,这些数据表明,在机械负荷条件下,已经建立的溶骨性病变减少。MM是美国和欧洲第二常见的血液肿瘤,具有特征性溶骨性骨结构变化。该项目的目标是机械生物学的理解,机械刺激如何影响(重新)建模过程中的骨肿瘤微环境中建立MM和MM骨疾病的发病过程。我们的研究结果将帮助我们确定机械刺激作为合成代谢疗法治疗MM骨病的疗效。我们假设,机械刺激将通过激活已知的骨(再)建模途径(如RANK/RANKL和Wnt)来增加骨形成并减少骨吸收,这些途径被骨中的MM细胞有害地改变。我们研究骨吸收途径Notch是否参与机械刺激后的机械转导。我们将专门研究单独的机械负荷以及与Notch抑制相结合如何控制MM骨(重建)建模过程。为了在体外分析机械转导,我们使用小规模生物反应器系统,并在机械应变条件下共培养人间充质干细胞和MM细胞。在已经建立溶骨性MM骨病后,以及在MM肿瘤植入和骨病发生的同时,将对MOPC315.BM小鼠定时给予无创体内受控机械负荷。将通过纵向体内microCT成像以及常规组织形态学分析研究MM期间骨(重建)对机械载荷的响应。将结合组织学、生物化学和分子遗传学方法分析骨(重建)建模过程的分子机制。这项研究将有助于从根本上了解MM骨病对机械刺激的反应中合成代谢骨适应的机械生物学和分子机制。从这些实验中获得的知识将有助于开发治疗和预防MM骨病的新合成代谢策略。
英文摘要
Bones adapt to changing loads (so-called modeling) and have the capacity for self-repair and renewal (remodeling). These anabolic processes allow bones to perform their mechanical functions successfully over long periods of time. Local adaptive responses of bones to mechanical loading have been demonstrated most dramatically in athletes under training. Mechanical loading in form of exercise has further shown promising results in cancer patients to maintain bone structural strength and to prevent bone loss. We have preliminary data in our MOPC315.BM mouse model for multiple myeloma (MM) bone disease which demonstrate that already established osteolytic lesions decrease under conditions of mechanical loading. MM is the second most common hematological neoplasia in the USA and Europe with characteristic osteolytic bone structure changes. The goal of this project is a mechano-biological understanding of how mechanical stimulation influences (re)modeling processes in the bone tumor microenvironment of established MM and during onset of MM bone disease. Our results will help us to determine the efficacy of mechanical stimulation as an anabolic therapy to treat MM bone disease. We hypothesize that mechanical stimulation will increase bone formation and decrease bone resorption by activating known bone (re)modeling pathways (such as RANK/RANKL and Wnt), which are deleteriously altered by MM cells in bone. We study whether the osteoresorptive pathway Notch is involved in mechanotransduction after mechanical stimulation. We will specifically investigate how mechanical loading alone and in combination with inhibition of Notch controls MM bone (re)modeling processes. For analysis of mechanotransduction in vitro we use a small scale bioreactor system and co-cultivate human mesenchymal stem cells and MM cells under conditions of mechanical strain. Noninvasive in-vivo controlled mechanical loading will be administered to MOPC315.BM mice tibiae after already established osteolytic MM bone disease and simultaneously while MM tumor engraftment and bone disease are occurring. The bone (re)modelling response to mechanical loading during MM will be investigated by longitudinal in vivo microCT imaging as well as conventional histomorphometric analysis. The molecular mechanisms of the bone (re)modelling processes will be analyzed using a combination of histological, biochemical and molecular genetic methods. This study will contribute to a fundamental understanding of the mechano-biological and molecular mechanisms of anabolic bone adaptation during MM bone disease in response to mechanical stimuli. The knowledge gained from these experiments will aid in the development of novel anabolic strategies for treating and preventing MM bone disease.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1155/2019/5150634
发表时间: 2019-02
期刊: Stem Cells International
影响因子: 4.3
作者: [Fani Ziouti;R. Ebert;Maximilian Rummler;Melanie Krug;S. Müller-Deubert;M. Lüdemann;F. Jakob;B. Wi]
通讯作者: Fani Ziouti;R. Ebert;Maximilian Rummler;Melanie Krug;S. Müller-Deubert;M. Lüdemann;F. Jakob;B. Wi
An Early Myeloma Bone Disease Model in Skeletally Mature Mice as a Platform for Biomaterial Characterization of the Extracellular Matrix
骨骼成熟小鼠的早期骨髓瘤骨病模型作为细胞外基质生物材料表征的平台
DOI: 10.1155/2020/3985315
发表时间: 2020
期刊: Journal of Oncology
影响因子: --
作者: [Ziouti F, Prates Soares A, Moreno-Jiménez I, Rack A, Bogen B, Cipitria A, Zaslansky P, Jundt F]
通讯作者: Jundt F
Functional validation of novel drug targets in multiple myeloma by use of a targeted shRNA library
  • 批准号:
    370022528
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    Professorin Dr. Franziska Jundt
  • 依托单位:
Ursachen und Wirkungen von Transkriptionsfaktordefekten beim Morbus Hodgkin
  • 批准号:
    5350143
  • 项目类别:
    Clinical Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2001
  • 负责人:
    Professorin Dr. Franziska Jundt
  • 依托单位:
Charakterisierung der immunologischen und pathobiologischen Funktionen einer permanenten NF-kB Aktivität für die Entstehung von Hodgkin-Lymphomen
  • 批准号:
    5220454
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    1999
  • 负责人:
    Professorin Dr. Franziska Jundt
  • 依托单位:
Identification of the early footprint of myeloma bone disease: spatio-temporal mapping and quantifying of extracellular matrix biomarkers in murine model and human bone biopsies
  • 批准号:
    496963451
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Professorin Dr. Franziska Jundt
  • 依托单位:
国内基金
海外基金
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
  • 批准号:
    82372167
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    江继宏
  • 依托单位:
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
  • 批准号:
    82371140
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李姝娜
  • 依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈颖
  • 依托单位:
cGAS-STING激活IFN1反应介导噪声性耳蜗损伤机制研究
  • 批准号:
    82371152
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    冯艳梅
  • 依托单位: